Chemoinformaics analysis of alpha-Hexylcinnamaldehyde
| Molecular Weight | 216.324 | nRot | 7 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 8 |
| Exact Molecular Weight | 216.151 | nRing | 1 |
| Solubility: LogS | -5.113 | nHRing | 0 |
| Solubility: LogP | 4.574 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 39.1879 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.378 |
| Synth | 2.141 |
| Natural Product Likeliness | 0.609 |
| NR-PPAR-gamma | 0.934 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.512 |
| MDCK | 0.0000196 |
| BBB | 0.957 |
| PPB | 0.966253 |
| VDSS | 1.38 |
| FU | 0.0127944 |
| CYP1A2-inh | 0.98 |
| CYP1A2-sub | 0.421 |
| CYP2c19-inh | 0.925 |
| CYP2c19-sub | 0.14 |
| CYP2c9-inh | 0.816 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.228 |
| CYP3a4-inh | 0.151 |
| CYP3a4-sub | 0.181 |
| CL | 4.197 |
| T12 | 0.398 |
| hERG | 0.017 |
| Ames | 0.065 |
| ROA | 0.011 |
| SkinSen | 0.862 |
| Carcinogencity | 0.23 |
| EI | 0.986 |
| Respiratory | 0.917 |
| NR-Aromatase | 0.038 |
| Antiviral | Yes |
| Prediction | 0.757575 |